Replies to post #463780 on Anavex Life Sciences Corp (AVXL)

[williamssc]

Yes Missling is clearly targeting the mabs, so setting A-273 at half the cost would be great for Medicare plans.

[BakedLangostino]

I would be thrilled if we got $15k. But I also expect the price of the “mabs” to drop significantly within the next few years, and assuming we get FDA approval we are still a ways away from commercialization.

So, if the Mabs drop to $15k, I think Blarcamesine enters the picture at around 30% less. We’ll see…